ACBM · Acro Biomedical Co., Ltd.

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of the financial statements being issued. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025, financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”